Anavex Life Sciences Corp (AVXL)

[BIOChecker4]

Why? I’ve said it before and I’ll say it again. Anavex (Missling) has no credibility with Wall Street. Regardless of whatever merit the still-unproven science may have, any company that has financed its operations with a vulture investor, engaged in past stock manipulation schemes, has no track record of successful drug development and commercialization, is forever tainted. Biotech fund managers will never get investment committee approval to buy AVXL. Only a change in senior management, changes to the board, and maybe a corporate name change, will help fix the perception problem.